Showing 3681-3690 of 10623 results for "".
The WHO Push to Eliminate Malaria Worldwide
https://reachmd.com/programs/world-medical-news/who-push-eliminate-malaria-worldwide/8224/The battle to eliminate malaria globally by the year 2030 continues. Dr. Mary Leuchars reports.Plasma Biomarkers Associated with HF Hospitalization in Atrial Fibrillation
https://reachmd.com/programs/heart-matters/plasma-biomarkers-hf-hospitalization-atrial-fibrillation/54805/Target Locked in gMG: Why T2T Matters
https://reachmd.com/programs/cme/target-locked-in-gmg-why-t2t-matters/54768/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.Minimal By Design: Define MSE Endpoints
https://reachmd.com/programs/cme/minimal-by-design-define-mse-endpoints/54769/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.The IgG Clock: Redose Using IgG Kinetics
https://reachmd.com/programs/cme/the-igg-clock-redose-using-igg-kinetics/54772/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.Escalate With Intention: Stepwise, Target-Anchored Moves
https://reachmd.com/programs/cme/escalate-with-intention-stepwise-target-anchored-moves/54773/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.Turning Flares Into Function: Flag Uncontrolled Disease
https://reachmd.com/programs/cme/turning-flares-into-function-flag-uncontrolled-disease/54770/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.Shared Goals, Shared Gains: Align With Patient Preferences
https://reachmd.com/programs/cme/shared-goals-shared-gains-align-with-patient-preferences/54776/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.The 2-Point Signal: Apply ≥2-Point Rule
https://reachmd.com/programs/cme/the-2-point-signal-apply-2-point-rule/54777/Explore treat-to-target strategies and FcRn inhibitor use to guide outcomes-driven management of generalized myasthenia gravis.Marketing “Ozempic Makeovers”
https://reachmd.com/ma-issues-index/march-april-2026-issue/marketing-ozempic-makeovers/56640/How practices can adapt to rising GLP-1 RA weight loss demand